Navigation Links
Ellen Presby of The Nemeroff Law Firm Invited to Speak at Plaintiff-Only GranuFlo and Dialysis Products Seminar

DALLAS, Nov. 22, 2013 /PRNewswire/ -- The American Association for Justice (AAJ) has invited attorney Ellen Presby of the nationally recognized Nemeroff Law Firm to speak at the organization's Plaintiff-Only GranuFlo and Dialysis Products Seminar in New York City on Dec. 6, 2013. The seminar will offer legal developments, industry updates and trial techniques for cases involving the most widely-prescribed dry acid product in the dialysis industry today.


Presby, a trial attorney with Dallas-based Nemeroff Law Firm, was asked to speak during the Medical and Scientific Overview of GranuFlo Cases. The session will provide a generic overview of the process and mechanics of dialysis machines, an understanding of the science and chemistry of GranuFlo and the negative impacts experienced by patients.

"It's essential for attorneys to understand the science behind these cases," Presby said. "I'm honored to have the opportunity to share my knowledge and experience with this type of litigation."

With nearly three decades of trial experience, Presby is a sought-after speaker and will also be moderating a portion of the upcoming AAJ 2014 Winter Convention. She holds multiple legal victories against major corporations, including a role in a $1.275 billion pharmaceutical class action settlement, and was recently appointed to the plaintiff's steering committee for a major multidistrict pharmaceutical litigation. She specializes in personal injury and product liability cases and stands at the cutting edge of pharmaceutical law and trial techniques.

Presby has been listed as one of National Trial Lawyers Top 100 Lawyers from 2007 to 2012, a Texas Super Lawyer every year since 2003 and was named one of the top 50 female lawyers in Texas by Law & Politics Media and Texas Monthly magazine in 2004. She has served as Co- Chair of the State Bar of Texas Grievance Committee, and on the Boards of the Texas Trial Lawyers Association, the Public Justice Foundation, and the Dallas Chapter of the American Board of Trial Advocates.

About The Nemeroff Law Firm
With offices in Dallas, Houston, New Orleans and Pittsburgh, The Nemeroff Law Firm is a nationally recognized trial firm dedicated to helping individuals and families who suffer from asbestos related mesothelioma, harmful pharmaceuticals, and catastrophic personal injuries or death as a result of the wrongful or negligent conduct of others. Led by attorney Rick Nemeroff, the firm serves clients throughout the United States and Mexico, combining compassion and caring with aggressive litigation skills to deliver life-changing results.  For more information, contact The Nemeroff Law Firm at 866-435-1831, go to or follow them on Twitter.

SOURCE The Nemeroff Law Firm
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Spains Hospital Ruber Internacional celebrates 20 years of excellence in Gamma Knife radiosurgery
2. Bayer HealthCare Awards Veterinary Students $72,500 in Scholarship Funds for Communications Excellence
3. Philips Honored With Prestigious Respiratory Industry Excellence Award At AARC International Respiratory Congress
4. Excellence in High Intensity Focused Ultrasound (HIFU) Outcomes
5. Call for Entries - 2014 Medical Design Excellence Awards
6. Quality by Design - The Pathway to Manufacturing Excellence for Asias Pharmaceutical Industry
7. Par Pharmaceuticals Karen OConnor Receives 2013 Cardinal Health Supply Chain Excellence Award
8. Forschungsbasierte Pharmaindustrie fordert ein verstärktes Engagement seitens des öffentlich-privaten Sektors, um die Millennium-Entwicklungsziele (MDGs) schneller zu erreichen und um eine neue Entwicklungsagenda aufzustellen
9. Studies Show Excellent Outcomes With Strut-Based Breast Brachytherapy
10. Allscripts Announces 2013 Client Excellence Award Winners
11. Mary Ellen Mitchell Joins Citizens Rx PBM
Post Your Comments:
(Date:11/26/2015)... , November 26, 2015 ... the addition of the  "2016 Future ... European Therapeutic Drug Monitoring (TDM) Market: ... Intelligence, Emerging Opportunities"  report to their ... has announced the addition of the  ...
(Date:11/26/2015)... 2015 ... the  "2016 Future Horizons and Growth ... Marker Testing Market: Supplier Shares, Competitive ... offering.  --> ) ... "2016 Future Horizons and Growth Strategies ...
(Date:11/25/2015)... 2015  Linden Care, LLC, a retail specialty pharmacy ... patients suffering from chronic pain, said today that it ... Order (TRO) enjoining Express Scripts from unilaterally terminating the ... --> --> The company said ... options. --> --> ...
Breaking Medicine Technology:
(Date:11/27/2015)... ... 27, 2015 , ... According to an article published November 13th ... in Washington D.C. revolved around the fact that proper dental care, both at-home and ... the link between periodontal disease (more commonly referred to as gum disease) and diabetes. ...
(Date:11/27/2015)... ... ... A team of Swiss doctors has released a report on mesothelioma relapse and ... findings on the website. Click here to read the details now. ... were treated with chemotherapy followed by EPP surgery. Among the 106 patients who relapsed, ...
(Date:11/27/2015)... ... 27, 2015 , ... The print component of “Supporting Our ... Dallas, New York, Minneapolis, South Florida, with a circulation of approximately 250,000 copies ... a vast social media strategy and across a network of top news sites ...
(Date:11/27/2015)... Wilmington, DE (PRWEB) , ... November 27, 2015 ... ... a member of the well-respected Microsoft Dynamics SL User Group (MSDSLUG). Recognized as ... is an independent group of Microsoft Dynamics SL software users, partners, industry experts ...
(Date:11/27/2015)... CA (PRWEB) , ... November 27, 2015 , ... ... on Accreditation of Allied Health Education Programs (CAAHEP) awarded accreditation to its Diagnostic Medical ... of CAAHEP accredited colleges, as only one of twelve colleges and universities in the ...
Breaking Medicine News(10 mins):